P142 A retrospective analysis of the safety of tacrolimus use and its optimal cut-off concentration during pregnancy in women with systemic lupus erythematosus: study from two Japanese tertiary referral centers

Ähnliche Einträge

• Effect of remission, clinical remission with active serology, and glucocorticoid dosage on the pregnancy outcome of pregnant patients with systemic lupus erythematosus
  von: Takehiro Nakai, et al.
  Veröffentlicht: (2024-03-01)
• Combination of tacrolimus and mycophenolate mofetil in persistent proteinuria due to refractory childhood lupus nephritis
  von: Abdulaziz Almutairi, et al.
  Veröffentlicht: (2018-07-01)
• Mechanism of tacrolimus in the treatment of lupus nephritis
  von: Ming Wang, et al.
  Veröffentlicht: (2024-05-01)
• Effect of tacrolimus with mycophenolate mofetil or cyclophosphamide on the renal response in systemic lupus erythematosus patients
  von: Siqin Sun, et al.
  Veröffentlicht: (2024-12-01)
• Efficacy of tacrolimus plus glucocorticoid for lupus nephritis: a Meta-analysis
  von: Yi-xi Xing, et al.
  Veröffentlicht: (2024-09-01)